Technology Review visits an Amyris plant outside of Sao Paula, Brazil, and learns how the company turns sugar into diesel fuel.
IBM has found a new source of revenue: using its mathematicians' formulas in business services.
A start-up in Menlo Park, CA hopes to bring down the cost of organic light-emitting diode displays by making equipment for printing them on a large scale. Kateeva is testing a prototype large-area printer it will send to display manufacturers for testing next year.
One of the pioneers of the automated sequencing of genomes, Leroy Hood, talks about his work in personalized medicine, and the challenges that must be overcome.
NASA and General Motors have developed a humanoid robot called Robonaut2. It is more dexterous and human-like than its predecessor and other, similar robots. NASA hopes to use it for precursor missions to the moon or Mars, or to work side-by-side with astronauts on the space station. GM says the technology could be used in its manufacturing plants or put into its products. In the video engineers discuss the robots importance and demonstrate how it works.
Paul Thomas, a technical supervisor at MIT's Plasma Science and Fusion Center, has reached almost half a million students through his Mr. Magnet shows and millions more through television appearances.
An event showcases the intersection of design and technology.
Amy Wagers, investigator at Boston-based Joslin Diabetes Center and assistant professor of pathology at Harvard Medical School, explains the regenerative power of young blood.
Dan Barry, vice president and director of research and development at Worcester, MA-based David Clark Company, demonstrates the company's early prototype of the Constellation space suit, NASA's next suit for travel to the moon, Mars and beyond. The company is designing the new space suit in partnership with Houston-based Oceaneering International, who was awarded a $500 million contract from NASA.
Stem cell advance will help drug development.